Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-2039
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-20T22:01:33.463256Z
status: published
lens: p_space
sector: health
headline: Artificial intelligence for ophthalmic vessel segmentation: from multimodal imaging to clinical translation
dek: Artificial intelligence (AI)-based vessel segmentation converts color fundus photographs, scanning laser ophthalmoscopy (SLO), optical coherence tomography angiography (OCTA), structural OCT, and anterior-segment images into quantitative vascular biomarkers. Strong performance within individual datasets has not consistently yielded reliable clinical measurements because errors can arise during acquisition, anatomical preprocessing, vessel extraction, biomarker calculation, and deployment. This structured narrati…
gain_title: (none)
problem_title: AI vessel segmentation that performs well within single datasets has not consistently produced reliable clinical measurements, because errors can enter at every step from image acquisition to deployment.
trace_subject: (none)
gain_reading: (none)
gain_evidence: (none)
problem_reading: AI vessel segmentation that performs well within single datasets has not consistently produced reliable clinical measurements, because errors can enter at every step from image acquisition to deployment.
problem_evidence: Strong performance within individual datasets has not consistently yielded reliable clinical measurements because errors can arise during acquisition, anatomical preprocessing, vessel extraction, biomarker calculation, and deployment.
quick_read: This structured narrative review examines how AI converts several eye-imaging types, including fundus photographs, OCT and OCTA, into quantitative vascular biomarkers. It compares segmentation tasks across the retina, choroid, cornea and conjunctiva, and assesses model architectures from Transformers to foundation models.

The central message is that good scores on a single dataset do not guarantee dependable clinical measurements. The authors argue that usefulness depends on pipelines whose structural error, biomarker uncertainty and failure states can be audited. Because devices, labels and post-processing differ, the review does not rank studies, so no model is shown to be best.
limitation: Studies are not directly comparable because devices, data splits, labels and post-processing differ substantially, so the review summarizes metrics without ranking models.
tag: Evidence-backed problem
key_points: The review covers color fundus photographs, scanning laser ophthalmoscopy, OCTA, structural OCT and anterior-segment images. | It organizes evaluation into five levels: pixel overlap, centerline recovery, vascular topology, biomarker agreement and clinical actionability. | Public fundus and OCTA datasets are catalogued, and gaps in public anterior-segment vessel benchmarks are discussed. | Reported metrics are summarized without ranking studies because devices, data splits, labels and post-processing differ substantially.
rundown: The review separates distinct measurements that are easily conflated: structural OCT choroidal vascularity index versus OCTA choriocapillaris flow-deficit mapping, and true vessel segmentation versus global hyperemia grading.

It lists requirements for clinical translation: ocular-magnification correction, quality control of retinal layers and projection artifacts, external testing across devices and populations, and out-of-distribution rejection.

Further requirements include DICOM/PACS interoperability, prospective impact studies and regulation as software as a medical device.
sources:
- peer_reviewed | Frontiers in Medicine | https://doi.org/10.3389/fmed.2026.1912838 | 2026-10-19
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

10edc3af67a931d94a64526a4b8cad0147d2721c57254318db133fef7a7d1522

previous

0000000000000000000000000000000000000000000000000000000000000000